Bio Waivers

Bio Waivers Date 27 – 28 Febuary 2020, Location – Brussel, Belgium

Course Objectives:

Regulatory agencies have long recognized, that for some drug products, in vivo BA/BE may be self-evident, and, as such, will waive the requirement for in vivo evidence in certain circumstances (grant a biowaiver). The use of biowaivers is in the spirit of avoiding unnecessary human testing whenever possible and facilitate access to drugs. This course will focus on the various biowaivers types, the possibilities opened, but also the limitations. It will highlight the data needed and the way to present them.

Key topics:

  • Biowaiver principles
  • Biowaivers based on solutions
  • BCS based biowaivers
  • Strength biowaivers
  • Locally applied locally acting biowaivers
  • IVIVC based biowaivers
  • Data to support biowaivers
  • Regulatory aspects
  • What to include in the dossier

Training audience :

  • Project Managers
  • Regulatory Senior or Junior
  • Formulation Developers
  • Clinical Managers
  • Agencies Assessors
  • Biowaiver Scientists
  • BA/BE Managers

Registration Fee


Per Participant

About Brussels

Brussels, officially the Brussels-Capital Region, is a region of Belgium comprising 19 municipalities, including the City of Brussels, which is the capital of Belgium.

You may also be interested in our Well Pluging Masterclass

We also organize In-house training session on this topic, so if you are looking for In-house training in Decommissioning of Offshore Installations then click here. We Deliver In-house training for Decommissioning of Offshore Installations in all countries and all time zones

Start Time

9:00 am

February 27, 2020

Finish Time

5:00 pm

February 28, 2020


Brussels, Belgium

Online Registration.

Register Now

Check Our Program

View Agenda

Request Inhouse Training

Submit Program

For More Details/ Queries

:+44 2032 398083

: Send us an email

Our Facilitator